Unlike previous individual studies, our meta-analysis simultaneously evaluates IGF-1 in relation to both ischemic stroke risk and long-term functional prognosis, with subgroup analyses based on follow-up duration. This evidence concerns the gene IGF1 and ischemic stroke.